BEI
BMY icon

Benjamin Edwards Inc’s Bristol-Myers Squibb BMY Stock Holding History

Benjamin Edwards Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.58M Buy
148,873
+18,656
+14% +$1.07M 0.08% 262
2026
Q1 		$7.9M Buy
130,217
+15,011
+13% +$875K 0.08% 253
2025
Q4 		$6.21M Buy
115,206
+1,751
+2% +$84.2K 0.07% 268
2025
Q3 		$5.12M Buy
113,455
+1,411
+1% +$65.9K 0.06% 292
2025
Q2 		$5.19M Sell
112,044
-4,273
-4% -$210K 0.07% 270
2025
Q1 		$7.09M Buy
116,317
+410
+0.4% +$23.9K 0.1% 207
2024
Q4 		$6.56M Buy
115,907
+672
+0.6% +$37.5K 0.09% 225
2024
Q3 		$5.96M Buy
+115,235
New +$5.41M 0.09% 242
2024
Q2 		– Sell
-264
Closed -$14K – 723
2024
Q1 		$14K Buy
264
+168
+175% +$8.56K ﹤0.01% 609
2023
Q4 		$5K Hold
96
– – ﹤0.01% 606
2023
Q3 		$6K Sell
96
-4,493
-98% -$275K ﹤0.01% 596
2023
Q2 		$293K Sell
4,589
-2
-0% -$134 0.07% 221
2023
Q1 		$318K Buy
4,591
+796
+21% +$56.1K 0.08% 216
2022
Q4 		$273K Buy
3,795
+285
+8% +$21.5K 0.07% 230
2022
Q3 		$250K Sell
3,510
-5,231
-60% -$379K 0.08% 223
2022
Q2 		$673K Buy
8,741
+5,169
+145% +$394K 0.2% 140
2022
Q1 		$261K Buy
3,572
+648
+22% +$43.5K 0.08% 246
2021
Q4 		$182K Buy
2,924
+1,944
+198% +$114K 0.06% 273
2021
Q3 		$58K Buy
980
+384
+64% +$25.3K 0.04% 283
2021
Q2 		$40K Buy
596
+45
+8% +$2.93K 0.03% 287
2021
Q1 		$35K Buy
551
+137
+33% +$8.52K 0.03% 270
2020
Q4 		$26K Hold
414
– – 0.02% 284
2020
Q3 		$25K Buy
414
+10
+2% +$602 0.02% 268
2020
Q2 		$24K Sell
404
-180
-31% -$10.8K 0.02% 249
2020
Q1 		$33K Sell
584
-6
-1% -$367 0.03% 196
2019
Q4 		$38K Buy
590
+144
+32% +$8.25K 0.08% 138
2019
Q3 		$23K Buy
446
+312
+233% +$14.7K 0.05% 157
2019
Q2 		$6K Buy
134
+53
+65% +$2.47K 0.01% 251
2019
Q1 		$4K Buy
+81
New +$4.04K 0.02% 249

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Benjamin Edwards Inc's BMY Position: Q2 2026 in Review

Benjamin Edwards Inc increased its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, buying an estimated $1.07M and bringing the position to 148,873 shares worth $8.58M. The position accounts for 0.08% of the portfolio, ranked #262.

Benjamin Edwards Inc first reported a position in BMY in Q1 2019 and has held it in 29 quarters since. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Benjamin Edwards Inc held 148,873 shares of Bristol-Myers Squibb worth $8.58M as of Q2 2026.
  • Benjamin Edwards Inc bought 18,656 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.07M.
  • Bristol-Myers Squibb made up 0.08% of Benjamin Edwards Inc's portfolio in Q2 2026, its #262 holding.
  • Benjamin Edwards Inc first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 29 quarters since.
  • 814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.